Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$47,484,964
-$10,346,796 QoQ
Shares Held
51,627
-4.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 41.05216262808221.ToString("F0")%
Shared 0.ToString("F0")%
None 58.9478373719178.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2026CallValue
$1,838
CallShares
2
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Orion Porfolio Solutions, LLC holds $221,310,249 across 15 Drug Manufacturers - General names. LLY ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
226,615 | $55,393,769 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
51,627 | $47,484,964 | |
| 3 | ABBV |
AbbVie Inc.
|
138,202 | $30,057,552 | |
| 4 | AZN |
Astrazeneca PLC
|
80,263 | $15,829,467 | |
| 5 | MRK |
Merck & Co., Inc.
|
124,118 | $14,930,153 | |
| 6 | PFE |
Pfizer Inc
|
446,491 | $12,537,466 | |
| 7 | AMGN |
Amgen Inc
|
27,190 | $9,566,800 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
68,638 | $9,566,077 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,838 | 2 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $47,484,964 | 51,627 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $57,831,760 | 53,813 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $37,728,824 | 49,448 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $39,618,053 | 50,823 | Shares | Sole | 2025-08-27 | |
| 2025-03-31 | $39,167,955 | 47,424 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $33,635,268 | 43,569 | Shares | Sole | 2025-08-01 | |
| 2024-09-30 | $33,880,117 | 38,242 | Shares | Sole | 2025-07-31 | |
| 2024-06-30 | $33,884,751 | 37,426 | Shares | Sole | 2025-07-31 | |
| 2024-03-31 | $27,893,755 | 35,855 | Shares | Sole | 2025-07-31 | |
| 2023-12-31 | $21,442,712 | 36,785 | Shares | Sole | 2025-07-31 | |
| 2023-09-30 | $20,562,947 | 38,283 | Shares | Sole | 2025-07-31 | |
| 2023-06-30 | $15,529,334 | 33,113 | Shares | Sole | 2025-07-31 | |
| 2023-03-31 | $13,070,221 | 38,059 | Shares | Sole | 2025-07-31 | |
| 2022-12-31 | $10,294,005 | 28,138 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $9,003,034 | 27,843 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $8,639,108 | 26,645 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $8,294,420 | 28,964 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,120,591 | 29,399 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $5,565,994 | 24,090 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $5,529,136 | 24,090 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $3,500,633 | 18,738 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $6,598,773 | 39,083 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,710,838 | 18,314 | Shares | Sole | 2020-12-03 | |
| No filing history on record for this holder in this stock. | ||||||